Magda Šišková

519 citations
22 papers · 395 indexed · h-index 10
Topics
Acute Myeloid Leukemia Research (15 papers)Chronic Myeloid Leukemia Treatments (5 papers)Multiple Myeloma Research and Treatments (3 papers)
Partner nations
CzechiaGuatemala

In The Last Decade

Magda Šišková

21 papers receiving 378 citations

Peers

Magda Šišková
Comparison fields: 5 of 35
  • Hematology 344
  • Genetics 131
  • Molecular Biology 123
  • Immunology 61
  • Genetics 57
Replace S. Alvi with:
S. Alvi United States
Ann‐Mari Forsblom Sweden
Barbara Rocca Italy
Marilena Caresana Italy
V. Parlier Switzerland
Jörg Chromik Germany
S. Fenu Italy
G.W. Dewald United States
U Hess Germany
Ulrich Pascheberg Germany
Magda Šišková relative to S. Alvi United States S. Alvi's profile →
Citations per field
00.5×10×14×
S. Alvi · 1×
Citations per year

Countries citing papers authored by Magda Šišková

Since Specialization
Citations

This map shows the geographic impact of Magda Šišková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Šišková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Šišková more than expected).

Fields of papers citing papers by Magda Šišková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Šišková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Šišková. The network helps show where Magda Šišková may publish in the future.

Co-authorship network of co-authors of Magda Šišková

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Šišková. A scholar is included among the top collaborators of Magda Šišková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Šišková. Magda Šišková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 2
4 21
5 6
6
[Lenalidomide treatment in myelodysplastic syndrome with 5q deletion--Czech MDS group experience].
1
7 24
8 26
9 1
10 14
11 31
12 5
13 37
14 1
15 13
16 13
17 25
18 3
19
Fifth International Symposium on Myelodysplastic Syndromes, Prague, Czech Republic, 21-24 April 1999
1
20 163

About Magda Šišková

Magda Šišková is a scholar working on Hematology, Genetics and Cancer Research, having authored 22 papers that have together received 395 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (344 citations), Genetics (131 citations) and Emergency Medicine (43 citations). Magda Šišková has collaborated with scholars based in Czechia and Guatemala. Frequent co-authors include R Neuwírtová, Jaroslav Čermák, Anna Jonášová, K Michalová, Jana Březinová, Zuzana Zemanová, Božena Novotná, Ota Fuchs, Monika Beličková and Jaroslav Poläk. Their work appears in journals such as Blood, British Journal of Haematology and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026